This company is a California-based biotechnology firm developing novel small molecule lipids, referred to as oxysterols.
Max BioPharma has raised $13.0M in total funding. The most recent round was Series A. The last funding was announced in March 2026.
Max BioPharma's investors include Technomark Life Sciences.
Max BioPharma is headquartered in Santa Monica, United States.
This company is a California-based biotechnology firm developing novel small molecule lipids, referred to as oxysterols.
Max BioPharma is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Max BioPharma — Funding & Investors." VCBacked, March 10, 2026, https://www.vcbacked.co/company/max-biopharma. Accessed August 17, 2026.
VCBacked. (2026). Max BioPharma — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/max-biopharma
{{cite web |title=Max BioPharma — Funding & Investors |url=https://www.vcbacked.co/company/max-biopharma |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated